genOway Société anonyme (EPA:ALGEN)

France flag France · Delayed Price · Currency is EUR
3.350
+0.050 (1.52%)
Jun 6, 2025, 1:21 PM CET
-23.86%
Market Cap 31.44M
Revenue (ttm) 27.53M
Net Income (ttm) 1.83M
Shares Out 9.22M
EPS (ttm) n/a
PE Ratio 17.17
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,394
Average Volume 2,867
Open 3.300
Previous Close 3.300
Day's Range 3.290 - 3.380
52-Week Range 2.400 - 4.690
Beta 0.47
RSI 63.78
Earnings Date Jun 23, 2025

About genOway Société anonyme

genOway Société anonyme, a biotechnology company, engages in the development and commercialization of custom genetically modified mouse, rat, and cell line models worldwide. It produces customized mouse models, such as knockout (KO) and knockin (KI) mouse models; customized rat models, including constitutive and conditional KO, point mutation KI, and quick KI rat models; and customized cell lines, such as constitutive and inducible KO, point mutation KI, reporter KI, quick KI, and KI cell lines. The company also offers humanized immune checkpoi... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1999
Employees 141
Stock Exchange Euronext Paris
Ticker Symbol ALGEN
Full Company Profile

Financial Performance

In 2024, genOway Société anonyme's revenue was 27.53 million, an increase of 3.85% compared to the previous year's 26.51 million. Earnings were 1.83 million, an increase of 16.79%.

Financial Statements

News

There is no news available yet.